{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:37:43Z","timestamp":1791005863987,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Atypical glandular cells (AGC) in cervical cytology are often ignored, and the malignancy risk associated with AGC remains uncertain. This study aims to evaluate the histopathology and clinical correlations in patients diagnosed with AGC through cervical cytology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was retrospectively analyzed 402 patients who diagnosed with AGC using cervical cytology in our hospital between March 2017 and June 2024. Among these, high-risk human papillomavirus (hrHPV) results and histopathological findings within 1-year follow-up were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The distribution of AGC subcategories were as follows: atypical endocervical cells (AEC), 13.4%; atypical endometrial cells, 10.9%; AGC, not otherwise specified, 49.8%; AEC, favor neoplastic, 6.7%; AGC, favor neoplastic, 19.2%. Precancerous lesions and malignancies were diagnosed in 58.9% of cases, with endometrial carcinoma being the most common (24.4%), followed by adenocarcinoma (10.0%). A total of 358 patients underwent hrHPV testing, with a positive rate of 35.2%, hrHPV positivity significantly increased the risk of cervical lesions, while endometrial lesions and pelvic malignancies were more common in hrHPV-negative patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study showed that cytological diagnosis of AGC has high predictive value for cervical lesions, endometrial lesions, and pelvic malignancies. A more detailed triage procedure based on the AGC subcategory can reduce the possibility of missed diagnoses of reproductive tract tumors. The combination of hrHPV detection and age can serve as an important basis for the further diagnosis and management of AGC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000000969","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:00:21Z","timestamp":1745578821000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The relationship between atypical glandular cells and malignancy risk: a retrospective single-center study"],"prefix":"10.1097","volume":"35","author":[{"given":"Lihua","family":"Tao","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongni","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoning","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"R1-20251211","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/1055-9965.EPI-20-1384","article-title":"Risk of gynecologic cancer after atypical glandular cells found on cervical cytology: a population-based cohort study.","volume":"30","author":"Aitken","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R2-20251211","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000342744","article-title":"Identification of atypical glandular cells in pap smears: is it a hit and miss scenario?","volume":"57","author":"Ajit","year":"2013","journal-title":"Acta Cytol"},{"key":"R3-20251211","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/IGC.0000000000000260","article-title":"Adenocarcinoma in situ of the uterine cervix--a systematic review.","volume":"24","author":"Baalbergen","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R4-20251211","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/JOC.JOC_209_16","article-title":"Histological follow-up in patients with atypical glandular cells on pap smears.","volume":"34","author":"Boyraz","year":"2017","journal-title":"J Cytol"},{"key":"R5-20251211","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/1055-9965.EPI-05-0231","article-title":"Incidence trends of adenocarcinoma of the cervix in 13 European countries.","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R7-20251211","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/AOG.0b013e3181c799a3","article-title":"Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks.","volume":"115","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R8-20251211","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-0528.2010.02769.x","article-title":"Risk of gynaecological malignancies in cytologically atypical glandular cells: follow-up study of a nationwide screening population.","volume":"118","author":"Cheng","year":"2011","journal-title":"BJOG"},{"key":"R9-20251211","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/cyt.13383","article-title":"Atypical glandular cells and predictive features of malignancy in pap smears: a retrospective monocentric study.","volume":"35","author":"Cianfrini","year":"2024","journal-title":"Cytopathology"},{"key":"R10-20251211","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.5858\/arpa.2018-0603-CP","article-title":"Bethesda 2014 implementation and human papillomavirus primary screening: practices of laboratories participating in the College of American Pathologists pap education program.","volume":"143","author":"Davey","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"R11-20251211","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/01.AOG.0000218705.87329.4a","article-title":"Rate of pathology from atypical glandular cell pap tests classified by the Bethesda 2001 nomenclature.","volume":"107","author":"Desimone","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R12-20251211","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jasc.2024.05.002","article-title":"Cytology-histology correlation of atypical glandular cells on cervical Papanicolaou tests: a study of 628 cases.","volume":"13","author":"Hassan","year":"2024","journal-title":"J Am Soc Cytopathol"},{"issue":"5 Suppl 1","key":"R13-20251211","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/LGT.0b013e3182854282","article-title":"Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade pap results.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R14-20251211","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/dc.24549","article-title":"Subcategorization of atypical glandular cells is useful to identify lesion site.","volume":"48","author":"Kawano","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"R15-20251211","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jasc.2017.03.003","article-title":"Bethesda interobserver reproducibility study-2 (birst-2): Bethesda system 2014.","volume":"6","author":"Kurtycz","year":"2017","journal-title":"J Am Soc Cytopathol"},{"key":"R16-20251211","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1309\/HL0B-C7Y6-AC77-ND2U","article-title":"Atypical glandular cells of undetermined significance (agus): interobserver reproducibility in cervical smears and corresponding thin-layer preparations.","volume":"117","author":"Lee","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R17-20251211","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.","volume":"9","author":"Mccredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"R19-20251211","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/ijc.34242","article-title":"Atypical glandular cells and development of cervical cancer: population-based cohort study.","volume":"151","author":"Norman","year":"2022","journal-title":"Int J Cancer"},{"key":"R20-20251211","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors.","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R21-20251211","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/modpathol.2014.55","article-title":"HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases.","volume":"27","author":"Pirog","year":"2014","journal-title":"Mod Pathol"},{"key":"R22-20251211","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S1470-2045(20)30524-6","article-title":"Efficacy of the bivalent HPV vaccine against HPV 16\/18-associated precancer: long-term follow-up results from the costa rica vaccine trial.","volume":"21","author":"Porras","year":"2020","journal-title":"Lancet Oncol"},{"key":"R23-20251211","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R24-20251211","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2023.05.011","article-title":"The combined finding of HPV 16, 18, or 45 and cytologic atypical glandular cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.","volume":"174","author":"Schiffman","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R25-20251211","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.AOG.0000202401.29145.68","article-title":"Clinical significance of atypical glandular cells on cervical cytology.","volume":"107","author":"Schnatz","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R26-20251211","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R27-20251211","doi-asserted-by":"crossref","first-page":"i276","DOI":"10.1136\/bmj.i276","article-title":"Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.","volume":"352","author":"Wang","year":"2016","journal-title":"BMJ"},{"key":"R28-20251211","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/LGT.0000000000000730","article-title":"Clinical diagnostic value of atypical glandular cells in cervical cytology: a single center experience from China.","volume":"27","author":"Xiao","year":"2023","journal-title":"J Low Genit Tract Dis"},{"key":"R29-20251211","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3802\/jgo.2017.28.e32","article-title":"Clinical statistics of gynecologic cancers in Japan.","volume":"28","author":"Yamagami","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"R30-20251211","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2009.05.019","article-title":"Histologic follow-up results in 662 patients with pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods.","volume":"114","author":"Zhao","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R31-20251211","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cncy.22780","article-title":"Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with atypical glandular cells cytology: a retrospective analysis of 369 cases.","volume":"132","author":"Zhou","year":"2024","journal-title":"Cancer Cytopathol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T14:00:20Z","timestamp":1765461620000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000969","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}